MEI Pharma Inc. Announces Board Changes: Steven D. Wood Resigns, Joshua Riezman Appointed as New Director
Reuters
Aug 07
MEI Pharma Inc. Announces Board Changes: Steven D. Wood Resigns, Joshua Riezman Appointed as New Director
MEI Pharma Inc. announced that Steven D. Wood has resigned from the board of directors, effective immediately. The board has elected Joshua Riezman to fill the vacancy. Riezman is the Managing Director and Head of U.S. Legal and Compliance for GSR Strategies, LLC.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-103990), on August 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.